Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Rapid Treatment of PTSD With Accelerated Non-Invasive Brain Stimulation

NCT: NCT06544408 · RECRUITING

NCT IDNCT06544408
StatusRECRUITING
Start Date2024-11-06
Completion2028-12-30

Brief Summary

This study will test the clinical efficacy of an accelerated TMS (accel-TMS) protocol that rapidly addresses PTSD symptoms with 1 week (25 sessions over 5 days) of condensed treatment.

Frequently Asked Questions

What is Rapid Treatment of PTSD With Accelerated Non-Invasive Brain Stimulation?

Rapid Treatment of PTSD With Accelerated Non-Invasive Brain Stimulation is a clinical trial registered under NCT06544408. Current status: RECRUITING.

What is the status of NCT06544408?

The current status of NCT06544408 (Rapid Treatment of PTSD With Accelerated Non-Invasive Brain Stimulation) is: RECRUITING.

When did Rapid Treatment of PTSD With Accelerated Non-Invasive Brain Stimulation start?

Rapid Treatment of PTSD With Accelerated Non-Invasive Brain Stimulation started on 2024-11-06.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.